Dhaka, June 27 -- Beximco Pharmaceuticals Limited has resumed trading on the London Stock Exchange after a suspension of nearly six months over its failure to publish annual financial results on time.

The exchange lifted the freeze on Friday, with trading in the company's Global Depositary Receipts (GDRs) resuming on the Alternative Investment Market (AIM) on Friday and Saturday.

The exchange informed investors that Beximco Pharma had published its financial reports, which were now available on the platform.

The company's GDRs were suspended from 7:30am London time on Jan 2 after it said in December that it would miss the Dec 31 deadline to publish its annual report and audited accounts for the financial year ending Jun 30, 2025, under...